Hidradenitis suppurativa – the most common disease your patient has never heard of. It’s not as rare as we once thought and there are some critical ways you can help people with HS – we’ll talk about how you can bust myths, educate your patient, and change their lives!
Learning Objectives:
Recognize the clinical manifestations of HS.
Describe the factors that contribute to the pathogenesis of HS.
Describe the treatments for HS and their roles in a stage-based approach.
ANCC Credits: 1
Pharmacology Credit: 0.17 | 10 mins
Joslyn Kirby is a professor of dermatology at Penn State Hershey and President of the Hidradenitis Suppurativa Foundation. In clinic and through her research, she is focused on hidradenitis suppurativa. Consultant to AbbVie, Amgen, Incyte, Insmed, Janssen, Guidepoint,Moonlake, Novartis, and UCB. Will be discussing off-label medication(s).